Benign Prostatic Hyperplasia Antibody (YBPH-2): sc-69650

Benign Prostatic Hyperplasia Antibody (YBPH-2) is a mouse monoclonal IgG antibody that specifically recognizes Benign Prostatic Hyperplasia in human samples through immunofluorescence (IF) and immunohistochemistry with paraffin-embedded sections (IHCP). Benign Prostatic Hyperplasia (BPH) is a condition characterized by prostate gland enlargement, primarily affecting middle-aged and elderly men, marked by large nodule formation in the periurethral region. This enlargement can obstruct the urethra, causing urinary issues like urgency, decreased flow, and complications including recurrent urinary tract infections, bladder stones, and potential kidney failure from increased bacterial counts. The prostate′s role in producing seminal fluid for sperm nourishment and transport makes understanding prostate structure and associated proteins crucial for male reproductive health. Any structural changes can trigger conditions like BPH. Anti-Benign Prostatic Hyperplasia antibody (YBPH-2) serves as a valuable research tool for investigating prostate enlargement mechanisms and urinary health impacts, supporting the development of targeted therapies and better patient outcomes.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences